405 Heron Drive Suite 200
Swedesboro, NJ 08085
Ph 800.331.8272
www.wedgewoodpharmacy.com

Mitomycin and canine corneal scarring

For Veterinary Practices
Prescribe Now
For Pet & Horse Owners
Manage Your Prescriptions

Mitomycin C: a promising agent for the treatment of canine corneal scarring

Rangan Gupta1,2, Benjamin W. Yarnall1,3, Elizabeth A. Giuliano1,3, Jagat R. Kanwar4, Dylan G. Buss1,3, Rajiv R. Mohan1,2,3
Article first published online: 18 APR 2011
DOI: 10.1111/j.1463-5224.2011.00877.x
© 2011 American College of Veterinary Ophthalmologists

Keywords: canine; cornea; fibroblasts; mitomycin C

Abstract

Objective To evaluate the safety and efficacy of mitomycin C (MMC) in prevention of canine corneal scarring.

Methods With an in vitro approach using healthy canine corneas, cultures of primary canine corneal fibroblasts or myofibroblasts were generated. Primary canine corneal fibroblasts were obtained by growing corneal buttons in minimal essential medium supplemented with 10% fetal bovine serum. Canine corneal myofibroblasts were produced by growing cultures in serum-free medium containing transforming growth factor β1 (1 ng/mL). Trypan blue assay and phase-contrast microscopy were used to evaluate the toxicity of three doses of MMC (0.002%, 0.02% and 0.04%). Real-time PCR, immunoblot, and immunocytochemistry techniques were used to determine MMC efficacy to inhibit markers of canine corneal scarring.

Results A single 2-min treatment of 0.02% or less MMC did not alter canine corneal fibroblast or keratocyte phenotype, viability, or growth. The 0.02% dose substantially reduced myofibroblast formation (up to 67%; P < 0.001), as measured by the change in RNA and protein expression of fibrosis biomarkers (α-smooth muscle actin and F-actin).

Conclusion This in vitro study suggests that a single 2-min 0.02% MMC treatment to the canine corneal keratocytes is safe and may be useful in decreasing canine corneal fibrous metaplasia. In vivo studies are warranted.

View the full article from Veterinary Ophthalmology Vol. 14 Issue 3 in HTML or PDF

Wedgewood Pharmacy is providing a link to this abstract for veterinarians as an additional resource for further information. Registration with the Wiley Online Library is required to view the full article and fees may apply. Search WedgewoodPetRx.com for more information about